Pediatric Dermatology of North Texas remains at the forefront in the diagnosis and treatment of hemangiomas. These lesions represent benign vascular growths that are quite common and can occur in 10% of infants.
In the first 4-6 months of life, hemangiomas typically exhibit a period of growth known as the proliferating phase. The next phase, called the involuting phase, corresponds to the shrinkage of the hemangioma over time. There can be lots of individual variability in the rate and degree of growth and involution. It is important to recognize that involution does NOT translate into the disappearance of the hemangioma, as residual color change and redundant (extra) skin can be left behind.
Many hemangiomas involute spontaneously and may not require therapy. Our providers at Pediatric Dermatology of North Texas work closely with the families of patients to help decide what is best for their child. Hemangiomas with potential complications are given consideration for treatment. Decisions to treat take into account multiple factors, including location, type (segmental vs focal), number, size, stage (proliferating vs involuting), physical functioning, potential anatomic disfigurement, emotional impact, and the overall family’s comfort with therapy.
Options include observation, topical therapies, oral therapies, laser, and surgery. All of these treatment options are discussed in detail with the family and treatment is individualized for each patient.